scholarly journals Histomorphological Spectrum of Glomerulopathies: A Review

2021 ◽  
Keyword(s):  
Renal Disease ◽  
Renal Biopsy ◽  
Public Health Problem ◽  
Glomerular Diseases ◽  
Nephritic Syndrome ◽  
Positive Impression ◽  
Stage Renal Disease ◽  
End Stage ◽  
Disease Analysis ◽  
Morphological Patterns

Renal disease and dysfunction is a worldwide public health problem. The underlying pathology in most renal disease is glomerulopathy, largely referred to as glomerulonephritis. It can be primary or secondary to other diseases. A range of morphological patterns was observed in this condition, each with different etiopathogenetic mechanisms, diverse clinical presentation, disease progression and therapeutic responses. We searched the literature using Hinari, PubMed and Google Scholar, for appropriate studies. This review was conducted by employing specified methods and structures using histopathology-confirmed data during the year 2011 to 2020. Thirty-five studies consisting of 13,423 reported renal biopsy cases were covered in this review. The most common indication of the renal biopsy was nephrotic syndrome followed by proteinuria and nephritic syndrome. Focal segmental glomerulosclerosis, minimal change disease, and mesangio-capillary glomerulonephritis among others, were the most frequently reported primary patterns of glomerulopathies. Glomerular diseases remain poorly characterized due to the scarcity of data on histo-morphological patterns of glomerulopathies. The development of registries regarding renal biopsy may offer a chance to characterize the pervasiveness and patterns of glomerulopathies and have a positive impression on chronic/end stage renal disease analysis and treatment since most glomerular diseases are complaisant to treatment.

scholarly journals Immune Deposits in Glomerular Diseases and Their Clinical, Histopathological and Immunopathological Correlation

1970 ◽  
Vol 26 (1) ◽  
pp. 14-19 ◽  
Author(s):  
Md Towhid Hossain ◽  
Morshida Begum ◽  
AJE Nahar Rahman ◽  
Mohammed Kamal
Keyword(s):  
Renal Disease ◽  
Renal Biopsy ◽  
Microscopic Study ◽  
Clinical Presentation ◽  
Frequent Pattern ◽  
Direct Immunofluorescence ◽  
Intensity Pattern ◽  
Glomerular Diseases ◽  
Stage Renal Disease ◽  
End Stage

Glomerulonephritis (GN) is a common renal disease and common cause of chronic renal failure (CRF) accounts for more than one-third of patients of end stage renal disease (ESRD) requiring either dialysis or transplantation. In our country, early diagnosis and treatment of GN depends on routine urine and blood examination and using light and immunofluorescent microscopic study of renal biopsy. The purpose of this study was to demonstrate the frequency, type, intensity, pattern and site of deposition of immunoglobulin IgG, IgA, IgM and C3 by direct immunofluorescence microscopic technique (DIF) in various pattern of GN and to correlate with clinical and histopathological findings. Among 120 cases of renal biopsy, 110 cases (91.67%; n=120) were adequate for histopathologic study only and 98 cases (81.67%; n=120) were adequate for both histopathologic and direct immunofluorescence microscopic study. In this series, maximum numbers of cases were found in 21-30 age group (27.27%). Most frequent clinical presentation and pattern of glomerulonephritis were nephrotic syndrome (61.22%; n=98) and mesangioproliferative GN (40.81%) respectively. Among 98 cases of study group, 49 cases (50%; n=98) were DIF positive. The most frequent type of depositions were C3 (type) in various combinations (98%; n=49) followed by IgG (67.35%) and IgA (40%). Mesangium followed by glomerular basement membrane were the most frequent site and granular pattern was the most frequent pattern of deposition. The frequent combination of depositions in various pattern of GN were C3 + IgG (36.73%; n=49) followed by C3 + IgA (20.41%). There was a correlation between histopathologic pattern of GN and type-site-pattern of deposition in the glomeruli. Immune-depositions were cent percent in IgA nephropathy, membranous GN (MGN), diffuse proliferative GN and membranoproliferative GN. Among 15 cases of IgA neph.ropathy (15.31%; n=98), most frequent pattern and clinical presentation of GN was mesangioproliferative GN (60%; n=15) and haematuria (46.67; n=15) respectively. In this study, DIF was proved to be essential, sensitive and specific diagnostic tool in the evaluation of glomerular diseases. However, DIF study is no substitute of light microscopy but both provide information which when taken as a whole contributes to better understanding of GN. Key words: DIF; GN; CRF; ESRD DOI: http://dx.doi.org/10.3329/bjpath.v26i1.9129 BJPATH 2011; 26(1): 14-19

The role of VEGF rs699947 polymorphism in End-Stage Renal Disease: A preliminary study

2021 ◽  
pp. 19-23
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Protective Factor ◽  
Public Health Problem ◽  
Turkish Population ◽  
Control Group ◽  
Case Group ◽  
Important Public Health Problem ◽  
Stage Renal Disease ◽  
End Stage

Aim: End-Stage Renal Disease (ESRD) is an important public health problem worldwide with an increasing incidence and prevalence. There are many environmental and genetic factors which contribute to the development of ESRD. Vascular endothelial growth factor (VEGF) has been suggested to play an important role in renal pathophysiology. The aim of this study was to determine the probable relation between ESRD and VEGF gene rs699947 polymorphism in Turkish population. Material and Method: Genotyping of rs699947 was carried out in 50 ESRD patients on dialysis treatment and 30 healthy controls, using a Kompetitive Allelic-Specific PCR (KASP) method following DNA isolation. Demographic and clinical characteristics of the patients were recorded. Results: The prevalance of rs699947 AA genotype was found to be higher in the control group, but it was not statistically significant (p>0.05) . Conclusion: Although statistically insignificant, the frequency of AA genotype was higher in the control group compared to the case group, therefore we concluded that AA genotype may be a protective factor for ESRD in Turkish population. However, this conclusion needs to be further verified by future studies performed in larger study groups.

The Frequency of Pulmonary Hypertension among End Stage Renal Disease Patients on Hemodialysis

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Irfan Mirza ◽  
Ahmad Zeb Khan ◽  
Mufti Baleegh ◽  
Amirullah . ◽  
Tahir Rashid ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Public Health Problem ◽  
Sampling Technique ◽  
Global Public Health ◽  
Endstage Renal Disease ◽  
Mortality And Morbidity ◽  
Stage Renal Disease ◽  
End Stage

Background: Chronic kidney disease is one of the global public health problem. It is a major cause of mortality and morbidity. Endstage renal disease patients will have either option of renal transplant or dialysis. Although dialysis is an effective form of renalreplacement therapy but it also have long term side effects. Pulmonary hypertension is one of them.Objective: To find frequency of pulmonary hypertension among end stage renal disease patients on hemodialysis in our populationMaterial and Methods: In this study a total of 163 patients were included, using 18.8% prevalence of pulmonary hypertension inend stage renal disease patients on hemodialysis, with 95% confidence interval and 6% margin of error, using WHO software. Moreover non-probability consecutive sampling technique was used for sample collection.Results: Our study shows that mean age was 52 years with SD ± 8.21. Fifty five percent patients were male and 73(45%) patientswere female. Forty eight percent patients had pulmonary hypertension.Conclusion: Our study concludes that the incidence of pulmonary hypertension was found to be one of the major contributingfactor among end stage renal disease patients on hemodialysis in our population.

Renal medicine

2021 ◽  
pp. 353-382
Author(s):  
Gopesh K. Modi ◽  
Vivekanand Jha
Keyword(s):  
Kidney Disease ◽  
Renal Disease ◽  
Rapidly Progressive Glomerulonephritis ◽  
Kidney Injury ◽  
Renal Stones ◽  
Renal Diseases ◽  
Acute Glomerulonephritis ◽  
Glomerular Diseases ◽  
Stage Renal Disease ◽  
End Stage

Assessing renal function, Urinalysis, Proteinuria, Hematuria, Chyluria, Imaging in renal disease, Kidney biopsy, Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD), Diabetic Nephropathy, End Stage Renal Disease and Dialysis, Kidney Transplantation, Glomerular diseases, Acute glomerulonephritis, Urinary schistosomiasis (bilharzia), Infections and Kidney Disease, Rapidly Progressive glomerulonephritis, Tubulointerstitial Disease, Urinary Tract Infection, Vesico-ureteric reflux, Renal Stones, Renal Disease in Pregnancy, Renal Artery Stenosis, Renal Mass, Inherited Renal Diseases

scholarly journals Novel Haplotype Indicator for End-Stage Renal Disease Progression among Saudi Patients

2019 ◽  
Vol 2019 ◽  
pp. 1-6
Author(s):  
Cyril Cyrus ◽  
Shahanas Chathoth ◽  
Chittibabu Vatte ◽  
Nafie Alrubaish ◽  
Othman Almuhanna ◽  
...  
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Haplotype Analysis ◽  
Taqman Assay ◽  
Rapid Progression ◽  
High Morbidity ◽  
Glomerular Diseases ◽  
Increased Risk ◽  
Stage Renal Disease ◽  
End Stage

Background. End-stage renal disease (ESRD) is the result of hypertensive nephrosclerosis and chronic glomerular diseases and is associated with high morbidity and mortality. There are strong heritable components in the manifestation of the disease with a genetic predisposition to renal disorders, including focal segmental glomerulosclerosis and arterionephrosclerosis. Recent studies in genetics have examined modifiable risk factors that contribute to renal disease, and this has provided a deep insight into progressive kidney disease. Single-nucleotide polymorphisms at the proximity of SHROOM3, CST3, SLC7A9, and MYH9 genes have been associated with an increased risk of developing CKD and ESRD. Methods. A total of 160 CKD patients and 189 control subjects of Saudi origin participated in the study. Eight polymorphisms (SHROOM3-rs9992101, rs17319721; SLC7A9-rs4805834; MYH9-rs4821480, rs4821481, rs2032487, rs3752462; CST3-rs13038305) were genotyped using TaqMan assay, and the haplotype analysis was done using the HaploView 4.2 software. Results. Haplotype analysis revealed a novel haplotype “E6”-GTTT to be associated significantly with an increased risk for ESRD (p=0.0001) and CKD (p=0.03). Conclusion. CKD is often silent until symptomatic uremia during the advanced stages of the disease. The newly identified haplotype will help recognize patients at risk for a rapid progression of CKD to ESRD. Accurate detection and mapping of the genetic variants facilitates improved risk stratification and development of improved and targeted therapeutic management for CKD.

scholarly journals Declining Rates of Hip Fracture in End-Stage Renal Disease: Analysis From the 2003-2011 Nationwide Inpatient Sample

2017 ◽  
Vol 32 (11) ◽  
pp. 2297-2303 ◽  
Author(s):  
Sun Moon Kim ◽  
Sai Liu ◽  
Jin Long ◽  
Maria E Montez-Rath ◽  
Mary B Leonard ◽  
...  
Keyword(s):  
Hip Fracture ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Nationwide Inpatient Sample ◽  
Stage Renal Disease ◽  
End Stage ◽  
Disease Analysis

scholarly journals Obesity is not associated with progression to end stage renal disease in patients with biopsy-proven glomerular diseases

2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Benjamin M. P. Elyan ◽  
Jennifer S. Lees ◽  
Keith A. Gillis ◽  
Bruce Mackinnon ◽  
Jonathan G. Fox ◽  
...  
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Glomerular Diseases ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Apolipoprotein c-iii (apo-c3) Metabolism in Patients with End Stage Renal Disease Treated with Long Term Hemodialysis

2018 ◽  
Vol 2 (2) ◽  
pp. 174-181
Author(s):  
Lutfi Zylbeari ◽  
Kastriot Haxhirexha ◽  
Nasir Behxheti ◽  
Ferizate Dika- Haxhirexha ◽  
Gazmend Zylbeari ◽  
...  
Keyword(s):  
Renal Disease ◽  
Kidney Failure ◽  
End Stage Renal Disease ◽  
Public Health Problem ◽  
Chronic Kidney Failure ◽  
The United States ◽  
Coronary Syndrome ◽  
Poor Outcomes ◽  
Stage Renal Disease ◽  
End Stage

Background: End Stage Renal disease (ESRD) as it was historically termed is a term that encompasses all degrees of decreased renal function, from damaged–at risk through mild, moderate, and severe chronic kidney failure. ESRD is a worldwide public health problem. In the United States, there is a rising incidence and prevalence of kidney failure, with poor outcomes and high cost (see Epidemiology).Material and Methods: The blood sample for routine analysis (lipidogram) and specific analysis was taken at 08o'clock in the morning with the room temperature that variated from 19 to 24°C, before the hemodialysis session, minimum 12 hours of fasting - with tendency to avoid the absorption effect of food by the intestine as well as avoid absorption of lipids and formation of chilomicrones. In all samples regardless of their group, the concentration of ApoC-II and lipids were analyzed in a period of 12 months in a period of 12 months (the measurements were made every three months, it means we totally made 3 measurements in 9 months).Results: The results from patients and controlling group for Apo-C3 and lipid profile (ChT, TG, HDL-ch, LDL-ch) are given in table number 3. A significant statistical difference with p<0.0001 is found from the results of the lipidic profile and ApoC-III of patients with ESRD treated with HD compared with the results of the controlling group for the same parameters.Conclusion: In this study patients with ESRD treated with HD have high parameters of ApoC-III, TG, LDL-ch but low concentrations of HDL-ch due to impaired catabolism of apolipoproteins in this specific group of patients. In all patients symptoms of CDV (myocardial infarction, angina pectoris, ischemia), acute coronary syndrome were noticed.

Sign in / Sign up

Export Citation Format

Share Document